We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

Back to rankings

1,007 hedge funds and large institutions have $35.8B invested in Allergan plc in 2018 Q4 according to their latest regulatory filings, with 127 funds opening new positions, 280 increasing their positions, 486 reducing their positions, and 175 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 1,067 → 1,007 (-60)

12% less call options, than puts

Call options by funds: $745M | Put options by funds: $846M

27% less first-time investments, than exits

New positions opened: 127 | Existing positions closed: 175

31% less capital invested

Capital invested by funds: $51.7B → $35.8B (-$15.9B)

33% less funds holding in top 10

Funds holding in top 10: 49 → 33 (-16)

42% less repeat investments, than reductions

Existing positions increased: 280 | Existing positions reduced: 486

Holders
1,007
Holders Change
-60
Holders Change %
-5.62%
% of All Funds
22.43%
Holding in Top 10
33
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-32.65%
% of All Funds
0.74%
New
127
Increased
280
Reduced
486
Closed
175
Calls
$745M
Puts
$846M
Net Calls
-$102M
Net Calls Change
+$90.2M

Top Buyers

Rank Fund Capital Flow
1
LP
Longview Partners
Guernsey
+$734M
2
Artisan Partners
Artisan Partners
Wisconsin
+$520M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$407M
4
KSCM
King Street Capital Management
New York
+$207M
5
Renaissance Technologies
Renaissance Technologies
New York
+$132M

Top Sellers

Rank Fund Capital Flow
1
SIG
Senator Investment Group
New York
-$248M
2
GCM
Glenview Capital Management
New York
-$240M
3
JP Morgan Chase
JP Morgan Chase
New York
-$183M
4
State Street
State Street
Massachusetts
-$171M
5
Citadel Advisors
Citadel Advisors
Florida
-$156M
Name Holding Trade Value Shares
Change 		Change in
Stake
KSCM
26
King Street Capital Management
New York
$321M +$207M +1,265,000 +111%
SAM
27
Southeastern Asset Management
Tennessee
$287M -$24.2M -147,677 -6%
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$243M -$29.1M -177,272 -9%
Renaissance Technologies
29
Renaissance Technologies
New York
$242M +$132M +804,106 +80%
Morgan Stanley
30
Morgan Stanley
New York
$236M -$146M -892,723 -34%
Legal & General Group
31
Legal & General Group
United Kingdom
$223M +$17.5M +106,894 +7%
Deutsche Bank
32
Deutsche Bank
Germany
$222M -$21.8M -133,093 -7%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$215M +$2.15M +13,100 +0.8%
Wells Fargo
34
Wells Fargo
California
$211M -$33.8M -206,040 -12%
PC
35
Paulson & Co
New York
$207M -$11.8M -72,000 -4%
Jennison Associates
36
Jennison Associates
New York
$200M -$46.7M -284,978 -16%
Charles Schwab
37
Charles Schwab
California
$178M +$6.99M +42,622 +3%
Newport Trust Company
38
Newport Trust Company
District of Columbia
$172M -$2.08M -12,665 -1%
IAM
39
Iridian Asset Management
Connecticut
$168M +$21.3M +129,761 +11%
American Century Companies
40
American Century Companies
Missouri
$165M +$35.2M +214,955 +21%
Prudential Financial
41
Prudential Financial
New Jersey
$154M +$9.79M +59,748 +5%
AL
42
Appaloosa LP
New Jersey
$154M -$138M -842,591 -42%
Swiss National Bank
43
Swiss National Bank
Switzerland
$147M +$3.48M +21,200 +2%
EIP
44
Epoch Investment Partners
New York
$146M -$13.5M -82,564 -7%
TSW
45
Thompson Siegel & Walmsley
Virginia
$141M +$8.92M +54,436 +5%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$139M -$2.96M -18,028 -2%
SSM
47
Sound Shore Management
Connecticut
$136M +$45.8M +279,693 +38%
Barclays
48
Barclays
United Kingdom
$136M +$40.9M +249,359 +33%
CCM
49
Camber Capital Management
Massachusetts
$134M +$16.4M +100,000 +11%
1832 Asset Management
50
1832 Asset Management
Ontario, Canada
$131M -$10.1M -61,500 -6%
1
2
3 4 5

AGN Hedge Fund Activity: Q4 2018 in Review

1,007 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2018, worth a combined $35.8B — down 31% from $51.7B a quarter earlier.

Sellers outnumbered buyers: 175 funds closed out of AGN and 127 opened new positions — a net loss of 48 holders — while 486 trimmed existing stakes and 280 added.

The largest buyer was Longview Partners, adding an estimated $734M. The largest seller was Senator Investment Group, exiting entirely with an estimated $248M sold.

  • 1,007 institutional investors held Allergan plc (AGN) as of Q4 2018, down from 1,067 in Q3 2018.
  • Funds reported $35.8B of Allergan plc stock for Q4 2018, down 31% quarter-over-quarter.
  • 127 funds opened new Allergan plc positions in Q4 2018 and 175 closed out, a net change of -48 holders.
  • The largest Allergan plc buyer in Q4 2018 was Longview Partners, an estimated $734M added.
  • The largest Allergan plc seller in Q4 2018 was Senator Investment Group, an estimated $248M sold.

Based on aggregated 13F filings for Q4 2018.